ACS Infectious Diseases · 2024 · 10 citations · 24 references
Life SciencesInfectious DiseasesPharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibiotic ResistanceCombination Antimicrobial TherapyMultidrug ResistanceResistance In Gram-negative BacteriaAcinetobacter Baumannii InfectionAcinetobacter Baumannii ResistanceAntibiotic CombinationsBeta-lactamase InhibitorsDiclofenac TherapyEscherichia ColiMultidrug-resistant Gram-negative BacteriaTreatment Of Bacterial Resistance
The continuous rise of multidrug-resistant (MDR) Gram-negative bacteria poses a severe threat to public health worldwide. Colistin(COL), employed as the last-line antibiotic against MDR pathogens, is now at risk due to the emergence of colistin-resistant (COL-R) bacteria, potentially leading to adverse patient outcomes. In this study, synergistic activity was observed when colistin and diclofenac sodium (DS) were combined and used against clinical COL-R strains of Escherichia coli ( E. coli ), Klebsiella pneumoniae ( K. pneumoniae ), Acinetobacter baumannii ( A. baumannii ), and Pseudomonas aeruginosa ( P. aeruginosa ) both in vitro and in vivo. The checkerboard method and time-killing assay showed that DS, when combined with COL, exhibited enhanced antibacterial activity compared to DS and COL monotherapies. Crystal violet staining and scanning electron microscopy showed that COL-DS inhibited biofilm formation compared with monotherapy. The in vivo experiment showed that the combination of DS and COL reduced bacterial loads in infected mouse thighs. Synergistic activity was observed when COL and DS were use in combination against clinical COL-R strains of E. coli, K. pneumoniae, A. baumannii and P. aeruginosa both in vitro and in vivo. The synergistic antibacterial effect of the COL-DS combination has been confirmed by performing various in vitro and in vivo experiments, which provides a new treatment strategy for infections caused by MDR bacteria.
24
Yiyun Liu, Yang Wang, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2015 · 5.4K citations
Anastasia Antoniadou, Flora Kontopidou, G. Poulakou et al. · Journal of Antimicrobial Chemotherapy · 2007 · 271 citations